{"groups":[{"description":"Neoadjuvant total androgen suppression (TAS) - Flutamide and Zoladex or Lupron - two months before and during radiation therapy.","id":"FG000","title":"Hormone Therapy + Radiation Therapy"},{"description":"Radiation therapy alone","id":"FG001","title":"Radiation Therapy Alone"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"19"},{"groupId":"FG001","numSubjects":"17"}],"type":"Protocol Violation"},{"reasons":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"6"}],"type":"Withdrawal by Subject"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"1013"},{"groupId":"FG001","numSubjects":"1015"}],"type":"STARTED"},{"achievements":[{"comment":"Subjects with data available for the primary analysis are considered to have completed the study.","groupId":"FG000","numSubjects":"987"},{"comment":"Subjects with data available for the primary analysis are considered to have completed the study.","groupId":"FG001","numSubjects":"992"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"26"},{"groupId":"FG001","numSubjects":"23"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}